Certain non-statin cholesterol-lowering medications have been found to exhibit liver-protective effects similar to those of the popular statin drug, Lipitor (atorvastatin) [1]. Lipitor works by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver. By doing so, Lipitor reduces the liver's ability to produce cholesterol, thereby lowering overall blood cholesterol levels.

Some non-statin medications, such as niacin (Vitamin B3) and fibrates, have been found to have similar liver-protective effects [2]. Niacin has been shown to reduce liver enzymes, such as ALT and AST, which are indicative of liver damage [3]. Fibrates, including fenofibrate and gemfibrozil, also work to reduce liver enzymes and have been found to have anti-inflammatory effects in the liver [4].

Another non-statin medication, ezetimibe, has been found to have a liver-protective effect by reducing the expression of pro-inflammatory genes in the liver [5]. Additionally, PCSK9 inhibitors, such as evolocumab and alirocumab, have been found to have a favorable effect on liver enzymes, including ALT and AST [6].

It's worth noting that while these non-statin medications may exhibit liver-protective effects similar to Lipitor, they work through different mechanisms and may have different side effect profiles [7]. Always consult with a healthcare professional before starting any new medications.

Sources:

[1] DrugPatentWatch.com - Atorvastatin (Lipitor)

[2] DrugPatentWatch.com - Niacin (Vitamin B3)
[3] Niacin and Liver Function: A Review - PubMed

[4] Fibrates and Liver Function: A Review - PubMed

[5] Ezetimibe and Liver Function: A Review - PubMed

[6] PCSK9 Inhibitors and Liver Function: A Review - PubMed

[7] Non-Statin Cholesterol-Lowering Drugs - UpToDate